Artidis Company
ARTIDISTM is our nanomechanical sensor that captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue in under three hours.
Technology:
Nanotechnology
Industry:
BioTech
Headquarters:
Basel
Founded Date:
2017
Employees Number:
11-50
Total Funding:
CHF8.8M
Estimated Revenue:
$1M to $10M
Register and Claim Ownership